Submit your email to push it up the queue
Guangzhou Gloria Biosciences Co., Ltd., commonly referred to as Gloria Biosciences, is a leading player in the biotechnology industry, headquartered in Guangzhou, China. Established in 2009, the company has made significant strides in the development of innovative biopharmaceuticals and diagnostic products, focusing on areas such as molecular diagnostics and therapeutic solutions. With a commitment to quality and innovation, Gloria Biosciences offers a range of unique products, including advanced reagents and diagnostic kits that cater to both clinical and research applications. The company has positioned itself as a trusted partner in the global market, achieving notable milestones in research and development. Its dedication to excellence has earned it recognition within the industry, solidifying its reputation as a key contributor to the advancement of biosciences.
How does Guangzhou Gloria Biosciences Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Guangzhou Gloria Biosciences Co., Ltd.'s score of 2 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Guangzhou Gloria Biosciences Co., Ltd. reported total carbon emissions of approximately 5,592,500 kg CO2e. This figure includes 1,688,580 kg CO2e from Scope 1 emissions and 3,903,920 kg CO2e from Scope 2 emissions. The company has not disclosed any Scope 3 emissions data. Currently, there are no specific reduction targets or climate pledges documented for Guangzhou Gloria Biosciences Co., Ltd. This indicates a potential area for improvement in their climate strategy, as many companies are increasingly setting science-based targets to align with global climate goals. The emissions data is not cascaded from any parent or related organization, indicating that the figures are solely representative of Guangzhou Gloria Biosciences Co., Ltd.'s own operations. As the company continues to navigate its environmental impact, establishing clear reduction initiatives and commitments could enhance its sustainability profile in the biotechnology sector.
Access structured emissions data, company-specific emission factors, and source documents
2022 | |
---|---|
Scope 1 | 1,688,580 |
Scope 2 | 3,903,920 |
Scope 3 | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Guangzhou Gloria Biosciences Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.